Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma

Krishnan, A; Nooka, AK; Chari, A; Garfall, AL; Martin, TG; Nair, S; Lin, XW; Qi, KQ; Londhe, A; Pei, LX; Ammann, E; Kobos, R; Smit, J; Parekh, T; Marshall, A; Slavcev, M; Usmani, SZ

Krishnan, A (通讯作者)，City Hope Comprehens Canc Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023; 12 (6):

Abstract

Aim: We compared the effectiveness of teclistamab versus real-world physician's choice of therapy (RWPC) in triple-class exposed relapsed/refractory m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索